Rapidoll
PARAPOX VIRUS OVIS IMMUNOSTIMULANT Rapidoll Prospectus Rapidoll Pharmaceutical Formulation: Suspension For Injection Target Species Horses, cattle, sheep, goats, cats and dogs and their newborn offspring Composition COMPOSITION: Inactived Parapoxvirus ovis E(P)CK strain: Minimum 256 interferon units per ml. Excipients Lactalbumin Hydrolysate: 0,25 mg/dose Sucrose: 0,50